0000000001286232

AUTHOR

Parvathy V Girija

showing 1 related works from this author

IL-17 Inhibition in Spondyloarthritis Associates with Subclinical Gut Microbiome Perturbations and a Distinctive IL-25-Driven Intestinal Inflammation

2020

To characterize the ecological effects of biologic therapies on the gut bacterial and fungal microbiome of psoriatic arthritis (PsA)/spondyloarthritis (SpA) patients.

Settore MED/16 - ReumatologiaIL-17 inhibitorPsoriatic arthritiSpondyloarthritisMicrobiomeCandida
researchProduct